home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

100.68 +1.85 (+1.87%)

Official Closing Price Updated: 7:00 PM EDT, Jul 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

56 57 Next >

Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know

April 16, 2025

Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) jumped 5.4% in the morning session after the company reported decent first-quarter 2025 results with revenue in line,...

Via StockStory

Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings ↗

April 16, 2025

Via Benzinga

Abbott Stock Rises On Strong Q1 Earnings: Retail’s In Wait-And-Watch Mode ↗

April 16, 2025

Abbott reaffirmed its full-year 2025 financial guidance and expects full-year 2025 adjusted diluted earnings per share of $5.05 to $5.25.

Via Stocktwits

Topics Government

Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty ↗

April 16, 2025

Abbott reaffirmed its 2025 EPS guidance supported by strong Diabetes and Nutrition growth.

Via Benzinga

Abbott Laboratories's Earnings Outlook ↗

April 15, 2025

Via Benzinga

Abbott Laboratories Dips As Sales Come In Light Despite Profit Beat ↗

April 16, 2025

Abbott stock slipped early Wednesday after the health giant reported light first-quarter sales, though profit beat views.

Via Investor's Business Daily

Abbott Laboratories (NYSE:ABT) Posts Q1 Sales In Line With Estimates

April 16, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4% year on year to $10.36 billion. Its non-GAAP profit of $1.09...

Via StockStory

Abbott Laboratories Reports Strong First Quarter Results, Maintains Positive Outlook ↗

April 16, 2025

Abbott Laboratories reported a strong start to 2025 with significant growth in sales and EPS, exceeding market expectations.

Via Talk Markets

Topics Stocks / Equities

US Stock Likely To Open Lower As US-China Tariff War Continues: 'Valuations Are Now Looking More Compelling,' Says Expert ↗

April 16, 2025

U.S. stock futures declined on Wednesday following a muted day of trading on Tuesday. Futures of indices were lower in premarket.

Via Benzinga

Earnings Scheduled For April 16, 2025 ↗

April 16, 2025

Via Benzinga

Dow Falls Over 150 Points Even As Citi, Bank Of America Earnings Beat Expectations: Greed Index Remains In 'Extreme Fear' Zone ↗

April 16, 2025

Via Benzinga

Topics Earnings Stocks

Abbott Laboratories, Travelers Companies And 3 Stocks To Watch Heading Into Wednesday ↗

April 16, 2025

Via Benzinga

This House of Representative Just Bought Up To $390K In Abbott Laboratories Stock ↗

April 15, 2025

Via Benzinga

How To Earn $500 A Month From Abbott Laboratories Stock Ahead Of Q1 Earnings ↗

April 15, 2025

Abbott Laboratories offers a quarterly dividend amount of 59 cents per share ($2.36 a year). Here's how investors can pocket $500 monthly.

Via Benzinga

Abbott Laboratories (ABT) Q1 Earnings: What To Expect

April 15, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results tomorrow before the bell. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

Recent Filing Shows That Rep. Josh Gottheimer Sold Over $32K Worth of Abbott Laboratories Stock ↗

April 11, 2025

Via Benzinga

Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device ↗

April 10, 2025

Dexcom stock surged Thursday after the FDA cleared its newest diabetes device for an extended 15-day wear time.

Via Investor's Business Daily

Topics Government Stocks World Trade

President Trump's Tariffs Have Arrived. 3 Things to Do to Protect Your Portfolio. ↗

April 05, 2025

Via The Motley Fool

Topics Economy Government Stocks

Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks

April 04, 2025

Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.

Via StockStory

2 Value Stocks I'm Buying Right Now ↗

April 01, 2025

Via The Motley Fool

Topics Economy

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades. ↗

March 31, 2025

Via The Motley Fool

Topics Intellectual Property Retirement

3 Relatively Safe Stocks to Buy Right Now ↗

March 29, 2025

Via The Motley Fool

Topics Intellectual Property

Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too? ↗

March 28, 2025

Via The Motley Fool

Topics ETFs Economy Government

Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday ↗

March 27, 2025

Via The Motley Fool

Which S&P500 stocks are moving on Thursday? ↗

March 27, 2025

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

March 27, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

From Rookie Mistakes To $10K/Year In Dividends – Military Veteran Who 'Made A Few Great Plays' Shares His 10 Biggest Bets ↗

March 27, 2025

Via Benzinga

2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income ↗

March 26, 2025

Via The Motley Fool

What Does the Market Think About Abbott Laboratories? ↗

March 20, 2025

Via Benzinga

No Quick Fix For This Market ↗

March 23, 2025

Despite the pullback, we have found numerous opportunities which we discuss in this video using technical analysis.

Via Talk Markets

Topics Stocks / Equities

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

56 57 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com